Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. HCI Group, Inc.

8.6% sales growth and 16.31% return on equity

HCI Group, Inc. engages in the property and casualty insurance, reinsurance, real estate, and information technology businesses in Florida.

HCI Group, Inc.’s sales growth this year is expected to be 27.7% and a negative 8.4% for next year.

Year-on-year quarterly revenue growth grew by 11.8%, now sitting on 266.39M for the twelve trailing months.

HCI Group, Inc.’s sales growth for the next quarter is 8.6%. The company’s growth estimates for the present quarter and the next is a negative 39.5% and 3.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.

Volatility

HCI Group, Inc.’s last day, last week, and last month’s average volatility was a negative 1.51%, a positive 0.47%, and a positive 0.09%, respectively.

HCI Group, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.90%, 3.01%, and 2.33%, respectively.

HCI Group, Inc.’s Stock Yearly Top and Bottom Value

HCI Group, Inc.’s stock is valued at $53.51 at 01:22 EST, way under its 52-week high of $62.93 and way above its 52-week low of $31.61.

HCI Group, Inc.’s Moving Average

HCI Group, Inc.’s value is higher than its 50-day moving average of $52.31 and above its 200-day moving average of $50.38.

2. Brown & Brown, Inc.

6.5% sales growth and 13.1% return on equity

Brown & Brown, Inc. markets and sells insurance products and services in the United States, England, Canada, Bermuda, and the Cayman Islands.

Brown & Brown, Inc.’s sales growth this year is expected to be 8.5% and 7.2% for next year.

Year-on-year quarterly revenue growth grew by 8.8%, now sitting on 2.54B for the twelve trailing months.

Brown & Brown, Inc.’s sales growth for the next quarter is 6.5%. The company’s growth estimates for the current quarter and the next is 3.6% and 3.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.1%.

Volatility

Brown & Brown, Inc.’s last day, last week, and last month’s average volatility was 1.38%, 0.70%, and 0.34%, respectively.

Brown & Brown, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.20%, 2.81%, and 2.06%, respectively.

Brown & Brown, Inc.’s Stock Yearly Top and Bottom Value

Brown & Brown, Inc.’s stock is valued at $47.88 at 01:22 EST, under its 52-week high of $48.69 and way above its 52-week low of $30.70.

Brown & Brown, Inc.’s Moving Average

Brown & Brown, Inc.’s value is above its 50-day moving average of $45.94 and higher than its 200-day moving average of $45.11.

3. Tempur Sealy International, Inc.

8.5% sales growth and 63.13% return on equity

Tempur Sealy International, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes bedding products in the United States, Canada, and internationally.

Tempur Sealy International, Inc.’s sales growth this year is expected to be 16.1% and 8.3% for next year.

Year-on-year quarterly revenue growth grew by 37.9%, now sitting on 3.49B for the twelve trailing months.

Tempur Sealy International, Inc.’s sales growth for the next quarter is 8.5%. The company’s growth estimates for the ongoing quarter and the next is 52.9% and 21.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 63.13%.

Volatility

Tempur Sealy International, Inc.’s last day, last week, and last month’s average volatility was a negative 0.54%, a positive 0.60%, and a positive 0.60%, respectively.

Tempur Sealy International, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.14%, 3.61%, and 3.59%, respectively.

Tempur Sealy International, Inc.’s Stock Yearly Top and Bottom Value

Tempur Sealy International, Inc.’s stock is valued at $27.80 at 01:22 EST, below its 52-week high of $28.65 and way above its 52-week low of $5.50.

Tempur Sealy International, Inc.’s Moving Average

Tempur Sealy International, Inc.’s value is higher than its 50-day moving average of $26.42 and way above its 200-day moving average of $22.50.

4. Broadcom Inc.

11% sales growth and 12.12% return on equity

Broadcom Inc. designs, develops, and supplies a range of semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide.

Broadcom Inc.’s sales growth this year is anticipated to be 10.2% and 3.9% for next year.

Year-on-year quarterly revenue growth grew by 12%, now sitting on 23.89B for the twelve trailing months.

Broadcom Inc.’s sales growth for the next quarter is 11%. The company’s growth estimates for the current quarter and the next is 24.8% and 20.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.12%.

Volatility

Broadcom Inc.’s last day, last week, and last month’s average volatility was 0.51%, 0.36%, and 0.25%, respectively.

Broadcom Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 2.59%, 3.16%, and 2.23%, respectively.

Broadcom Inc.’s Stock Yearly Top and Bottom Value

Broadcom Inc.’s stock is valued at $445.64 at 01:22 EST, under its 52-week high of $449.99 and way higher than its 52-week low of $155.67.

Broadcom Inc.’s Moving Average

Broadcom Inc.’s value is higher than its 50-day moving average of $418.70 and way higher than its 200-day moving average of $363.07.

5. Regeneron Pharmaceuticals, Inc.

34.3% sales growth and 30.6% return on equity

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide.

Regeneron Pharmaceuticals, Inc.’s sales growth this year is expected to be 8.7% and 19.6% for next year.

Year-on-year quarterly revenue growth grew by 31.6%, now sitting on 9.24B for the twelve trailing months.

Regeneron Pharmaceuticals, Inc.’s sales growth for the next quarter is 34.3%. The company’s growth estimates for the current quarter and the next is 12.3% and 27.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.6%.

Volatility

Regeneron Pharmaceuticals, Inc.’s last day, last week, and last month’s average volatility was 0.84%, 0.82%, and 0.14%, respectively.

Regeneron Pharmaceuticals, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.23%, 2.94%, and 2.47%, respectively.

Regeneron Pharmaceuticals, Inc.’s Stock Yearly Top and Bottom Value

Regeneron Pharmaceuticals, Inc.’s stock is valued at $502.92 at 01:22 EST, way below its 52-week high of $664.64 and way above its 52-week low of $328.13.

Regeneron Pharmaceuticals, Inc.’s Moving Average

Regeneron Pharmaceuticals, Inc.’s value is higher than its 50-day moving average of $494.19 and way below its 200-day moving average of $570.20.

6. Kimball Electronics, Inc.

9.2% sales growth and 7.38% return on equity

Kimball Electronics, Inc. provides contract electronics manufacturing services and diversified manufacturing services to customers in the automotive, medical, industrial, and public safety end markets.

Kimball Electronics, Inc.’s sales growth this year is expected to be 7.8% and 5.4% for next year.

Year-on-year quarterly revenue growth grew by 5.9%, now sitting on 1.22B for the twelve trailing months.

Kimball Electronics, Inc.’s sales growth is a negative 0% for the current quarter and 9.2% for the next. The company’s growth estimates for the current quarter and the next is a negative 0% and 44%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.38%.

Volatility

Kimball Electronics, Inc.’s last day, last week, and last month’s average volatility was a negative 2.05%, a positive 1.39%, and a positive 0.34%, respectively.

Kimball Electronics, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.29%, 3.34%, and 2.88%, respectively.

Kimball Electronics, Inc.’s Stock Yearly Top and Bottom Value

Kimball Electronics, Inc.’s stock is valued at $17.23 at 01:22 EST, below its 52-week high of $18.00 and way above its 52-week low of $9.78.

Kimball Electronics, Inc.’s Moving Average

Kimball Electronics, Inc.’s value is higher than its 50-day moving average of $15.94 and way above its 200-day moving average of $13.75.

LEAVE A REPLY

Please enter your comment!
Please enter your name here